OR1J2 inhibitors are a class of chemical compounds that specifically target and modulate the activity of the olfactory receptor OR1J2, a member of the G-protein-coupled receptor (GPCR) superfamily. Olfactory receptors like OR1J2 are primarily involved in the detection of odorant molecules and the initiation of signal transduction pathways that result in the perception of smell. OR1J2 belongs to a larger family of olfactory receptors, which are encoded by a vast gene family and exhibit a highly diverse sequence to recognize a wide array of volatile compounds. Inhibitors of OR1J2 can act by binding to the receptor in a way that prevents the activation of downstream signaling pathways, thereby modulating the receptor's ability to respond to odorant molecules. This interaction is primarily non-covalent, involving hydrogen bonding, van der Waals forces, and occasionally π-π interactions with aromatic residues within the binding pocket of OR1J2.
The structural basis for the design of OR1J2 inhibitors relies heavily on the identification of key motifs within the receptor that are responsible for ligand binding and activation. Molecular modeling and in silico docking studies have provided insight into the conformational changes that occur upon inhibitor binding. These inhibitors often possess a high degree of structural specificity, as minor alterations in their chemical structure can lead to significant changes in binding affinity and selectivity. Additionally, OR1J2 inhibitors are valuable for exploring the functional role of this receptor in olfactory signaling and its broader involvement in chemosensory pathways. By modulating OR1J2 activity, researchers can gain a deeper understanding of the molecular mechanisms underlying odorant recognition and signal transduction, which has implications for the study of GPCR biology and the complexity of olfactory systems in general.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ruthenium red | 11103-72-3 | sc-202328 sc-202328A | 500 mg 1 g | $188.00 $250.00 | 13 | |
Blocks calcium channels potentially involved in OR1J2 signaling pathways. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
Chelates intracellular calcium, which may be crucial for OR1J2 signaling. | ||||||
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $451.00 | 3 | |
Inactivates G-proteins that could be coupled to OR1J2, thus inhibiting downstream signaling. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Tyrosine kinase inhibitor that can modulate kinase-dependent OR1J2 signaling cascades. | ||||||
NF449 | 627034-85-9 | sc-478179 sc-478179A sc-478179B | 10 mg 25 mg 100 mg | $203.00 $469.00 $1509.00 | 1 | |
Potent Gs-alpha subunit inhibitor, possibly affecting OR1J2-mediated pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, which may play a role in OR1J2-mediated signaling processes. | ||||||
PD 168393 | 194423-15-9 | sc-222138 | 1 mg | $162.00 | 4 | |
Irreversible inhibitor of EGFR tyrosine kinase, impacting pathways OR1J2 may engage. | ||||||
KT 5720 | 108068-98-0 | sc-3538 sc-3538A sc-3538B | 50 µg 100 µg 500 µg | $138.00 $220.00 $972.00 | 47 | |
Inhibits protein kinase A, which could be involved in OR1J2 signal transduction. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
Inhibits myosin light chain kinase, affecting cytoskeletal changes linked to OR1J2 activation. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Non-selective protein kinase inhibitor that may disrupt OR1J2-associated signaling. | ||||||